These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30710416)

  • 21. Development of Heptylmannoside-Based Glycoconjugate Antiadhesive Compounds against Adherent-Invasive Escherichia coli Bacteria Associated with Crohn's Disease.
    Sivignon A; Yan X; Alvarez Dorta D; Bonnet R; Bouckaert J; Fleury E; Bernard J; Gouin SG; Darfeuille-Michaud A; Barnich N
    mBio; 2015 Nov; 6(6):e01298-15. PubMed ID: 26578673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heptyl α-D-mannosides grafted on a β-cyclodextrin core to interfere with Escherichia coli adhesion: an in vivo multivalent effect.
    Bouckaert J; Li Z; Xavier C; Almant M; Caveliers V; Lahoutte T; Weeks SD; Kovensky J; Gouin SG
    Chemistry; 2013 Jun; 19(24):7847-55. PubMed ID: 23595913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and evaluation of thiomannosides, potent and orally active FimH inhibitors.
    Sattigeri JA; Garg M; Bhateja P; Soni A; Rauf ARA; Gupta M; Deshmukh MS; Jain T; Alekar N; Barman TK; Jha P; Chaira T; Bambal RB; Upadhyay DJ; Nishi T
    Bioorg Med Chem Lett; 2018 Sep; 28(17):2993-2997. PubMed ID: 30017316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RMSD analysis of structures of the bacterial protein FimH identifies five conformations of its lectin domain.
    Magala P; Klevit RE; Thomas WE; Sokurenko EV; Stenkamp RE
    Proteins; 2020 Apr; 88(4):593-603. PubMed ID: 31622514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thiazolylaminomannosides as potent antiadhesives of type 1 piliated Escherichia coli isolated from Crohn's disease patients.
    Brument S; Sivignon A; Dumych TI; Moreau N; Roos G; Guérardel Y; Chalopin T; Deniaud D; Bilyy RO; Darfeuille-Michaud A; Bouckaert J; Gouin SG
    J Med Chem; 2013 Jul; 56(13):5395-406. PubMed ID: 23795713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the carbohydrate recognition domain of the bacterial adhesin FimH: Design, synthesis and binding properties of mannoside ligands.
    Sperling O; Fuchs A; Lindhorst TK
    Org Biomol Chem; 2006 Nov; 4(21):3913-22. PubMed ID: 17047870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physiochemical Tuning of Potent Escherichia coli Anti-Adhesives by Microencapsulation and Methylene Homologation.
    Alvarez Dorta D; Chalopin T; Sivignon A; de Ruyck J; Dumych TI; Bilyy RO; Deniaud D; Barnich N; Bouckaert J; Gouin SG
    ChemMedChem; 2017 Jun; 12(12):986-998. PubMed ID: 28257558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetic properties of carbohydrate-lectin interactions: FimH antagonists.
    Scharenberg M; Jiang X; Pang L; Navarra G; Rabbani S; Binder F; Schwardt O; Ernst B
    ChemMedChem; 2014 Jan; 9(1):78-83. PubMed ID: 24357503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition profiles of mono- and polyvalent FimH antagonists against 10 different Escherichia coli strains.
    Chalopin T; Brissonnet Y; Sivignon A; Deniaud D; Cremet L; Barnich N; Bouckaert J; Gouin SG
    Org Biomol Chem; 2015 Dec; 13(46):11369-75. PubMed ID: 26440382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthetic multimeric heptyl mannosides as potent antiadhesives of uropathogenic Escherichia coli.
    Gouin SG; Wellens A; Bouckaert J; Kovensky J
    ChemMedChem; 2009 May; 4(5):749-55. PubMed ID: 19343765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catch-bond mechanism of the bacterial adhesin FimH.
    Sauer MM; Jakob RP; Eras J; Baday S; Eriş D; Navarra G; Bernèche S; Ernst B; Maier T; Glockshuber R
    Nat Commun; 2016 Mar; 7():10738. PubMed ID: 26948702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Target Selectivity of FimH Antagonists.
    Scharenberg M; Schwardt O; Rabbani S; Ernst B
    J Med Chem; 2012 Nov; 55(22):9810-6. PubMed ID: 23088608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of an aggregation assay to screen FimH antagonists.
    Abgottspon D; Rölli G; Hosch L; Steinhuber A; Jiang X; Schwardt O; Cutting B; Smiesko M; Jenal U; Ernst B; Trampuz A
    J Microbiol Methods; 2010 Sep; 82(3):249-55. PubMed ID: 20620174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment and prevention of urinary tract infection with orally active FimH inhibitors.
    Cusumano CK; Pinkner JS; Han Z; Greene SE; Ford BA; Crowley JR; Henderson JP; Janetka JW; Hultgren SJ
    Sci Transl Med; 2011 Nov; 3(109):109ra115. PubMed ID: 22089451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interdomain interaction in the FimH adhesin of Escherichia coli regulates the affinity to mannose.
    Aprikian P; Tchesnokova V; Kidd B; Yakovenko O; Yarov-Yarovoy V; Trinchina E; Vogel V; Thomas W; Sokurenko E
    J Biol Chem; 2007 Aug; 282(32):23437-46. PubMed ID: 17567583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mannose-derived FimH antagonists: a promising anti-virulence therapeutic strategy for urinary tract infections and Crohn's disease.
    Mydock-McGrane LK; Cusumano ZT; Janetka JW
    Expert Opin Ther Pat; 2016; 26(2):175-97. PubMed ID: 26651364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-based discovery of glycomimetic FmlH ligands as inhibitors of bacterial adhesion during urinary tract infection.
    Kalas V; Hibbing ME; Maddirala AR; Chugani R; Pinkner JS; Mydock-McGrane LK; Conover MS; Janetka JW; Hultgren SJ
    Proc Natl Acad Sci U S A; 2018 Mar; 115(12):E2819-E2828. PubMed ID: 29507247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allosteric coupling in the bacterial adhesive protein FimH.
    Rodriguez VB; Kidd BA; Interlandi G; Tchesnokova V; Sokurenko EV; Thomas WE
    J Biol Chem; 2013 Aug; 288(33):24128-39. PubMed ID: 23821547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Second generation of thiazolylmannosides, FimH antagonists for E. coli-induced Crohn's disease.
    Chalopin T; Alvarez Dorta D; Sivignon A; Caudan M; Dumych TI; Bilyy RO; Deniaud D; Barnich N; Bouckaert J; Gouin SG
    Org Biomol Chem; 2016 Apr; 14(16):3913-25. PubMed ID: 27043998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conformational switch of the bacterial adhesin FimH in the absence of the regulatory domain: Engineering a minimalistic allosteric system.
    Rabbani S; Fiege B; Eris D; Silbermann M; Jakob RP; Navarra G; Maier T; Ernst B
    J Biol Chem; 2018 Feb; 293(5):1835-1849. PubMed ID: 29180452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.